Gelonghui, November 26th丨SciClone Pharmaceuticals (688321.SH) announced that on November 26, 2025, the company received a notification letter titled "Notice of Equity Change Reaching 1% Threshold and Completion of Share Reduction Plan" from its shareholder BioChain Biotech. Between October 14, 2025, and November 26, 2025, BioChain Biotech reduced its holdings in the company by a total of 12.2339 million shares through centralized bidding and block trading, representing 3% of the company’s total shares. This share reduction plan has now been fully implemented.
Microchip Biotech (688321.SH): Shareholder Bio-Orient Biotech Completes 3% Reduction in Company Shares
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Market Insights
Hot Stock Hot Stock
Top HK stocks viewed in the last 24 hours, capturing market sentiment and key capital flow insights. Top HK stocks viewed in the last 24 hours, capturing market sentiment and key capital flow insights.
View More
Hot Topics Hot Topics
Monthly Market Outlook: Peak Earnings Season! How to Navigate November?
In October, the U.S. stock market once again achieved a remarkable increase, with the three major indices hitting new record highs! Looking
年頭旺到年尾
Nov 3, 2025 06:28
October 31 review ..
年頭旺到年尾
Nov 6, 2025 09:38
Market Review on November 5th *